| Name | N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]-3,4,5-trimethoxybenzamide |
|---|---|
| Synonyms |
Galocitabinum [INN-Latin]
Cytidine,5'-deoxy-5-fluoro-N-(3,4,5-trimethoxybenzoyl) Galocitabine [INN] 5'-deoxy-5-fluoro-N4-(3,4,5-trimethoxybenzoyl)cytidine 5'-Deoxy-5-fluoro-N-(3,4,5-trimethoxybenzoyl)cytidine N4-Trimethoxybenzoyl-5'-deoxy-5-fluorocytidine Galocitabina [INN-Spanish] galocitabine Ro-09-1390 |
| Molecular Formula | C19H22FN3O8 |
|---|---|
| Molecular Weight | 439.39200 |
| Exact Mass | 439.13900 |
| PSA | 141.37000 |
| LogP | 0.37260 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
|
~%
124012-42-6 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 8, # 7 p. 1697 - 1706 |
|
~%
124012-42-6 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 8, # 7 p. 1697 - 1706 |
|
~%
124012-42-6 |
| Literature: Organic Letters, , vol. 14, # 13 p. 3348 - 3351 |
|
~%
124012-42-6 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 8, # 7 p. 1697 - 1706 |
|
~%
124012-42-6 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 8, # 7 p. 1697 - 1706 |
| Precursor 3 | |
|---|---|
| DownStream 4 | |